EPIRUS Biopharmaceuticals, Inc. Research and Development Expense
EPIRUS Biopharmaceuticals, Inc. reported Research and Development Expense of $10.34 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-05-10
- EPIRUS Biopharmaceuticals, Inc. research and development expense for the quarter ending 2016-03-31 was $10.34M, a 235.89% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for the quarter ending 2015-12-31 was $10.40M, a 116.74% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for the quarter ending 2015-09-30 was $9.17M, a 69.95% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for the quarter ending 2015-06-30 was $8.28M, a 219.87% increase year-over-year.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for fiscal 2015 was $30.93M, a 89.89% increase from fiscal 2014.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for fiscal 2014 was $16.29M, a 68.61% increase from fiscal 2013.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for fiscal 2013 was $9.66M, a 76.68% decline from fiscal 2012.
- EPIRUS Biopharmaceuticals, Inc. research and development expense for fiscal 2012 was $41.42M, a 17.37% increase from fiscal 2011.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | $10.34M 10-Q · filed 2016-05-10 | $20.74M derived: sum of 2 quarters · filed 2016-05-10 | $29.91M derived: sum of 3 quarters · filed 2016-05-10 | $38.19M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $19.57M derived: sum of 2 quarters · filed 2016-03-29 | $27.85M derived: sum of 3 quarters · filed 2016-03-29 | $30.93M 10-K · filed 2016-03-29 | ||||
| 2015-09-30 | $9.17M 10-Q · filed 2015-11-16 | $17.45M derived: sum of 2 quarters · filed 2015-11-16 | $20.53M 10-Q · filed 2015-11-16 | $25.32M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-06-30 | $8.28M 10-Q · filed 2015-08-12 | $11.35M 10-Q · filed 2015-08-12 | $16.15M derived: sum of 3 quarters · filed 2016-05-10 | $21.55M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2015-03-31 | $3.08M 10-Q · filed 2016-05-10 | $7.88M derived: sum of 2 quarters · filed 2016-05-10 | $13.27M derived: sum of 3 quarters · filed 2016-05-10 | $15.86M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $10.20M derived: sum of 2 quarters · filed 2016-03-29 | $12.78M derived: sum of 3 quarters · filed 2016-03-29 | $16.29M 10-K · filed 2016-03-29 | ||||
| 2014-09-30 | $5.40M 10-Q · filed 2015-11-16 | $7.98M derived: sum of 2 quarters · filed 2015-11-16 | $11.49M 10-Q · filed 2015-11-16 | $19.18M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $2.59M 10-Q · filed 2015-08-12 | $2.14M 10-Q · filed 2014-08-11 | $6.09M 10-Q · filed 2015-08-12 | $5.22M 10-Q · filed 2014-08-11 | $13.79M derived: sum of 3 quarters · filed 2015-08-12 | $15.72M derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | $3.50M 10-Q · filed 2015-05-13 | $3.08M 10-Q · filed 2014-05-09 | $11.20M derived: sum of 2 quarters · filed 2015-05-13 | $13.13M derived: sum of 3 quarters · filed 2015-05-13 | $22.97M derived: sum of 4 quarters · filed 2015-05-13 | |||
| 2013-12-31 | $7.70M 10-K · filed 2014-03-14 | $9.63M derived: sum of 2 quarters · filed 2014-11-10 | $19.47M derived: sum of 3 quarters · filed 2014-11-10 | $9.66M 10-K · filed 2015-03-31 | $33.96M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $1.93M 10-Q · filed 2014-11-10 | $9.34M 10-Q · filed 2013-11-04 | $11.77M derived: sum of 2 quarters · filed 2014-11-10 | $7.23M 10-Q · filed 2014-11-10 | $26.27M 10-Q · filed 2013-11-04 | $27.78M derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $9.85M 10-Q · filed 2014-08-11 | $16.92M 10-Q · filed 2014-08-11 | $25.85M derived: sum of 3 quarters · filed 2014-08-11 | $37.90M derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $7.08M 10-Q · filed 2014-05-09 | $16.01M derived: sum of 2 quarters · filed 2014-03-14 | $28.06M derived: sum of 3 quarters · filed 2014-03-14 | $37.92M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-12-31 | $8.93M 10-K · filed 2014-03-14 | $20.98M derived: sum of 2 quarters · filed 2014-03-14 | $30.84M derived: sum of 3 quarters · filed 2014-03-14 | $41.42M 10-K · filed 2014-03-14 | ||||
| 2012-09-30 | $12.05M 10-K · filed 2014-03-14 | $21.91M derived: sum of 2 quarters · filed 2014-03-14 | $32.49M 10-Q · filed 2013-11-04 | $42.11M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $9.86M 10-K · filed 2014-03-14 | $20.44M 10-Q · filed 2013-08-05 | $30.06M derived: sum of 3 quarters · filed 2014-03-14 | $38.93M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $10.58M 10-K · filed 2014-03-14 | $20.20M derived: sum of 2 quarters · filed 2014-03-14 | $29.07M derived: sum of 3 quarters · filed 2014-03-14 | $38.06M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $9.62M 10-K · filed 2013-03-07 | $18.49M derived: sum of 2 quarters · filed 2013-03-07 | $27.48M derived: sum of 3 quarters · filed 2013-03-07 | $35.29M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $8.87M 10-K · filed 2013-03-07 | $17.86M derived: sum of 2 quarters · filed 2013-03-07 | $25.68M 10-Q · filed 2012-11-08 | $31.63M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-06-30 | $8.99M 10-K · filed 2013-03-07 | $16.81M 10-Q · filed 2012-08-07 | $22.76M derived: sum of 3 quarters · filed 2013-03-07 | $27.82M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-03-31 | $7.82M 10-K · filed 2013-03-07 | $13.77M derived: sum of 2 quarters · filed 2013-03-07 | $18.83M derived: sum of 3 quarters · filed 2013-03-07 | $23.45M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2010-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $11.01M derived: sum of 2 quarters · filed 2013-03-07 | $15.63M derived: sum of 3 quarters · filed 2013-03-07 | $23.01M 10-K · filed 2013-03-07 | ||||
| 2010-09-30 | $5.06M 10-Q · filed 2011-11-04 | $9.68M derived: sum of 2 quarters · filed 2011-11-04 | $17.06M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $4.62M 10-Q · filed 2011-08-04 | $12.00M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $21.24M 10-K · filed 2012-03-09 |